Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma
Open Access
- 1 March 2013
- journal article
- research article
- Vol. 4 (1) , 45-52-52
Abstract
Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinomaKeywords
This publication has 28 references indexed in Scilit:
- Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?British Journal of Cancer, 2003
- Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcomeLiver Transplantation, 2003
- Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in TorontoGut, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinomaCancer, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization feverJournal of Hepatology, 1995
- Chemoembolization for hepatocellular carcinoma.Journal of Clinical Oncology, 1990
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985